You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Drugs Containing Excipient (Inactive Ingredient) MICROCRYSTALLINE CELLULOSE 200


✉ Email this page to a colleague

« Back to Dashboard


Generic drugs containing MICROCRYSTALLINE CELLULOSE 200 excipient

MICROCRYSTALLINE CELLULOSE 200 Market Analysis and Financial Projection Experimental

Microcrystalline Cellulose (MCC) Market Dynamics and Financial Trajectory

Introduction to Microcrystalline Cellulose

Microcrystalline cellulose (MCC) is a refined wood pulp or cotton-derived substance widely used in various industries, including pharmaceuticals, food and beverage, and cosmetics. Its unique physical and chemical properties make it an essential component in many formulations.

Market Size and Growth Projections

The global microcrystalline cellulose market is poised for significant growth over the coming years. Here are some key financial projections:

  • Current Market Size: The market was valued at approximately USD 1.2 billion in 2022[3] and USD 1,122.46 million in 2023[5].
  • Projected Market Size: It is expected to reach USD 2.1 billion by 2031[3], USD 2,095.05 million by 2032[5], and USD 2.4 billion by 2034[4].
  • Compound Annual Growth Rate (CAGR): The market is projected to grow at a CAGR of 6.6% from 2023 to 2030[2], 7.0% from 2023 to 2031[3], and 7.2% from 2024 to 2032[5].

Key Drivers of the Market

Several factors are driving the growth of the microcrystalline cellulose market:

Increasing Demand in Pharmaceuticals

The pharmaceutical industry is a major driver, with MCC used as a binder, filler, and disintegrant in tablet formulations. The rising demand for high-quality excipients due to the expansion of the pharmaceutical industry, driven by aging populations and increasing healthcare needs, is a significant factor[5].

Growing Use in Food and Beverage

MCC is used as a texturizer, anti-caking agent, fat substitute, emulsifier, extender, and bulking agent in food production. The increasing preference for natural and sustainable ingredients in food products is boosting its adoption[3].

Cosmetics and Personal Care

The cosmetics industry also relies heavily on MCC due to its absorbent properties. The rising demand for natural skin care products and the need for sustainable ingredients in beauty products are driving growth in this sector[4].

Environmental and Sustainability Factors

MCC is derived from renewable sources such as wood pulp, making it an environmentally favorable option. This aligns with the increasing global emphasis on sustainability, further driving its adoption[2].

Regional Market Dynamics

Europe

Europe accounted for the largest share of the global microcrystalline cellulose market in 2022. Countries like Germany are significant markets due to the high demand for natural and sustainable ingredients in pharmaceutical and cosmetic products[3][5].

North America

North America held the second largest share of the global market in 2022. Technological advancements and the growing demand for MCC in pharmaceutical and food applications are expected to propel the market in this region[3].

South Asia and Oceania

These regions are expected to experience the most rapid expansion due to increasing disposable incomes, population growth, and the adoption of Western lifestyles. Countries like India and Australia are driving demand for MCC in pharmaceuticals, food, and cosmetics[2].

Impact of COVID-19

The COVID-19 pandemic had a mixed impact on the microcrystalline cellulose market:

  • Pharmaceutical Sector: The pandemic led to an increase in the production of medicines, thereby increasing the demand for MCC in drug formulations[1].
  • Cosmetics and Beauty Industry: The pandemic resulted in a decline in sales and usage across many beauty segments due to lockdowns and retail closures. However, the long-term trend towards natural and sustainable products is expected to continue driving growth[1].

Market Competition and Innovation

The microcrystalline cellulose market is highly competitive, with both large international corporations and start-ups vying for market share. Companies are focusing on developing high-quality, low-cost MCC to increase their market share. Strategic alliances and partnerships are also on the rise to enhance production capabilities and meet the increasing demand[2][4].

Supply Chain and Manufacturing

The increase in manufacturing capacity is expected to positively impact the overall efficiency of the supply chain, leading to price stability and a more dependable supply of MCC. Innovations in production processes and the expansion of manufacturing facilities, such as the EXCiPACT certification for MCC production by Nordic Bioproducts Group, are key factors in this regard[5].

Regulatory Landscape

MCC is recognized for its safety and efficacy by major regulatory authorities, including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Its inclusion in pharmacopeia ensures stringent quality standards, further driving its adoption in the pharmaceutical industry[5].

Key Takeaways

  • The global microcrystalline cellulose market is expected to grow significantly, driven by increasing demand in pharmaceuticals, food and beverage, and cosmetics.
  • Europe and North America are key regions, with South Asia and Oceania expected to experience rapid growth.
  • The market is driven by the need for natural and sustainable ingredients, as well as the expanding pharmaceutical industry.
  • COVID-19 had a mixed impact, boosting demand in pharmaceuticals but affecting the cosmetics industry.
  • Market competition is high, with a focus on innovation and strategic partnerships.

FAQs

What are the primary applications of microcrystalline cellulose?

Microcrystalline cellulose is primarily used as a binder, filler, and disintegrant in pharmaceutical tablets and capsules. It also serves as a texturizer, anti-caking agent, fat substitute, emulsifier, extender, and bulking agent in food production and as an absorbent in cosmetics[2][3].

Which regions are expected to drive the growth of the microcrystalline cellulose market?

Europe, particularly Germany, and North America are currently significant markets. However, South Asia and Oceania, including countries like India and Australia, are expected to experience the most rapid expansion[2][3].

How has the COVID-19 pandemic impacted the microcrystalline cellulose market?

The pandemic increased demand for MCC in the pharmaceutical sector due to the higher production of medicines. However, it negatively impacted the cosmetics and beauty industry due to lockdowns and retail closures[1].

What are the key drivers of the microcrystalline cellulose market?

The key drivers include the increasing demand from the pharmaceutical industry, the growing use in food and beverage products, the rising demand for natural skin care products, and the emphasis on environmentally favorable and sustainable products[2][4].

Which companies are major players in the microcrystalline cellulose market?

Major players include Asahi Kasei Corporation, DuPont, Sigachi Industries Limited, DFE Pharma GmbH, Accent Microcell, Avantor, Inc., Quadra Chemicals, JRS Pharma, Huzhou City Linghu Xinwang Chemical Co., and FMC Corporation[3].

What is the expected CAGR of the microcrystalline cellulose market?

The market is expected to grow at a CAGR of 6.6% from 2023 to 2030, 7.0% from 2023 to 2031, and 7.2% from 2024 to 2032[2][3][5].

Sources

  1. Mordor Intelligence: Microcrystalline Cellulose Market Size & Share Analysis
  2. Persistence Market Research: Microcrystalline Cellulose Market Size & Share Report, 2030
  3. Transparency Market Research: Microcrystalline Cellulose Market Size, Statistics Report, 2031
  4. Prophecy Market Insights: Microcrystalline Cellulose Market Size is US$ 2.4 billion by 2034
  5. Polaris Market Research: Microcrystalline Cellulose Market Size, Share, Growth | Trends, 2032

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.